Targeting Programmed Cell Death as an Innovative Strategy Against Atherosclerosis: Potential of Natural Compound Supplements
Phytotherapy Research · 2025
DOI: 10.1002/ptr.70027 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2025. Written by Jilin Fan and 5 co-authors. Institution: Binzhou Medical University Hospital, Binzhou, Shandong, China. Major MEDLINE topics: Atherosclerosis, Apoptosis, Biological Products. Cited 7 times so far (Crossref); 329 references.
Abstract (original language)
Atherosclerosis (AS) is the primary pathological basis of various cardiovascular diseases. Its pathogenesis involves multiple processes, including inflammatory responses, lipid metabolism disorders, and cell death. Recently, programmed cell death (PCD), comprising apoptosis, autophagy, pyroptosis, necroptosis, and ferroptosis, has attracted considerable attention as a potential therapeutic target in AS progression. Furthermore, natural compounds with anti‐atherosclerotic properties derived from plants have gained wide interest. These natural products regulate PCD through various mechanisms and demonstrate significant potential for the prevention and treatment of AS. Therefore, this review summarizes the molecular mechanisms of critical PCD pathways involved in AS and discusses the latest findings on natural products, such as flavonoids, polyphenols, saponins, and alkaloids that target PCD to alleviate AS. Based on these findings, this review highlights the importance of natural compounds targeting PCD as a therapeutic strategy against AS, providing novel theoretical insights and translational directions to promote the development of precise anti‐atherosclerotic therapies derived from natural products.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Binzhou Medical University Hospital, Binzhou, Shandong, China.
- Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, Shandong, China.
- Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China.
ORCID profiles: Jilin Fan, Mengjie Wang
Cite
APA
Fan, J., Zhu, T., Tian, X., Wang, M., Li, Z., & Li, W. (2025). Targeting Programmed Cell Death as an Innovative Strategy Against Atherosclerosis: Potential of Natural Compound Supplements. Phytotherapy Research. https://doi.org/10.1002/ptr.70027
Vancouver
Fan J, Zhu T, Tian X, Wang M, Li Z, Li W. Targeting Programmed Cell Death as an Innovative Strategy Against Atherosclerosis: Potential of Natural Compound Supplements. Phytotherapy Research. 2025. doi:10.1002/ptr.70027
BibTeX
@article{Fan2025,
author = {Fan, Jilin and Zhu, Tingting and Tian, Xiaoling and Wang, Mengjie and Li, Zhichao and Li, Wei},
title = {Targeting Programmed Cell Death as an Innovative Strategy Against Atherosclerosis: Potential of Natural Compound Supplements},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.70027}
}
EUVIMED